Kapsin Pharma Private Limited

Kapsin Pharma Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U24299GJ2016PTC092322 Incorporated 03 June 2016 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹1.14 Cr
▲ 8% YoY
Net loss · FY 2025
₹2.83 Lakh
Net margin -2.5%
EBITDA · FY 2025
₹1.55 Lakh
EBITDA margin 1.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹11.95 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings

About Kapsin Pharma Private Limited

Data last updated:

Kapsin Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 June 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24299GJ2016PTC092322. Its GSTIN is 08AAGCK1876P1ZT (Rajasthan).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Mukesh Sharma and Gajraj Sharma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.14 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net loss of ₹2.83 Lakh (net margin -2.5%) and EBITDA of ₹1.55 Lakh (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 9% over five years.

As per MCA filings, the company has open charges of ₹11.95 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Kapsin Pharma Private Limited
CIN U24299GJ2016PTC092322
Registration Number 092322
Incorporation Date 03 June 2016
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    09:G.F; New Gokul Association Opp. Simandhar Apartment Janta Nagar Road Gh, Atlodia, Ahmedabad, Gujarat, India – 380061
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Kapsin Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Kapsin Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Kapsin Pharma Private Limited in one report.

Financials from FY 2017 Directors & ownership Charges & compliance

Business Activity of Kapsin Pharma Private Limited

The main business activity of Kapsin Pharma is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Kapsin Pharma Private Limited FY 2025 filings available

Kapsin Pharma Private Limited reported revenue of ₹1.14 Cr (up 8% YoY) for FY 2025.

Revenue · FY 2025
₹1.14 Cr ▲ 8%
Net loss · FY 2025
₹2.83 Lakh margin -2.5%
EBITDA · FY 2025
₹1.55 Lakh margin 1.4%

Compounded Annual Growth Rate (CAGR) of Kapsin Pharma Private Limited

Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▼ 5%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 122%
3 years · compounded
▼ 49%
5 years · compounded
▲ 17%

Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 8% growth in the latest year. EBITDA rose 122% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Kapsin Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹1.55 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹2.83 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Kapsin Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin1.4%••••••••••••••••
Net Profit Margin-2.5%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kapsin Pharma are in the company report.

Premium access

Financial statements from FY 2017

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Kapsin Pharma Private Limited

Kapsin Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Pazia Pharmaceuticals Private Limited₹1.14 Cr (FY 2025)••••••••820.0%••••Jaipur, Rajasthan, India
Apn Biotech Private Limited₹1.14 Cr (FY 2025)••••••••563.0%••••Noida, Uttar Pradesh, India
Vmedicare Private Limited₹1.14 Cr (FY 2024)••••••••295.0%••••Kalyan, Maharashtra, India
Pyramid Formulations Private Limited₹1.14 Cr (FY 2023)••••••••16.0%••••Salem, Tamil Nadu, India
Inspride Lab Private Limited₹1.14 Cr (FY 2019)••••••••82.0%••••Raipur, Chhattisgarh, India
Kapsin Pharma Private Limited this company₹1.14 Cr (FY 2025)••••••••8.0%••••Ahmedabad, Gujarat, India
Medixfora Healthcare Private Limited₹1.14 Cr (FY 2025)••••••••-31.0%••••Gurgaon, Haryana, India
Coz Drug Marketing Services Private Limited₹1.13 Cr (FY 2024)••••••••-10.0%••••Lucknow, Uttar Pradesh, India
Sam Marino Labs Private Limited₹1.13 Cr (FY 2024)••••••••23.0%••••Lucknow, Uttar Pradesh, India
Us Lifecare Private Limited₹1.13 Cr (FY 2017)••••••••-9.0%••••Vadodara, Gujarat, India
Karup Pharma Private Limited₹1.13 Cr (FY 2024)••••••••11.0%••••Hyderabad, Telangana, India

Peers are the five companies nearest above and the five nearest below Kapsin Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Kapsin Pharma Private Limited

Kapsin Pharma Private Limited is audited by JAIN CHOWDHARY & CO for the financial year 2022.

NameStatusAppointment DateCessation Date
JAIN CHOWDHARY & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Kapsin Pharma Private Limited

Kapsin Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Mukesh SharmaDirector03 Jun 201610 Years 4 MonthsCurrent
Gajraj SharmaDirector03 Jun 201610 Years 4 MonthsCurrent

Ownership and Shareholding of Kapsin Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Kapsin Pharma Private Limited

Open charges
₹11.95 Lakh
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹0.12 Cr
Latest charge details
DateLenderAmountStatus
30 Jan 2017State Bank of India₹11.95 LakhOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Kapsin Pharma Private Limited

Employment history and EPFO contributions of people linked to Kapsin Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Kapsin Pharma Private Limited

Kapsin Pharma Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Prince Kapoor ceased to be Director on 14 Aug 2019.

AGM
Kapsin Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Kapsin Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with State Bank Of India of Rs. 11.95 Lakh registered on 30 Jan 2017 with Charge ID 100081454 was modified on 22 Jun 2020.
Ceased
Prince Kapoor ceased to be Director.
Charges
A charge with State Bank Of India amounted to Rs. 11.95 Lakh with Charge ID 100081454 was registered on 30 Jan 2017.
Appointed
Gajraj Sharma was appointed as Director.
Appointed
Mukesh Sharma was appointed as Director.
Incorporation
03 Jun 2016
Kapsin Pharma Private Limited was registered on 03 Jun 2016 with Roc Ahmedabad & aged 10 years 4 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Kapsin Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Kapsin Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Kapsin Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Kapsin Pharma Private Limited

Kapsin Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
08AAGCK1876P1ZTRajasthanActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Kapsin Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kapsin Pharma Private Limited

Kapsin Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 June 2016 (10+ years old) and is registered under CIN U24299GJ2016PTC092322.

Kapsin Pharma reported revenue of ₹1.14 Cr for FY 2025 (up 8% YoY).

Kapsin Pharma has 2 current directors:

Kapsin Pharma reported a net loss of ₹2.83 Lakh (net margin -2.5%) and EBITDA of ₹1.55 Lakh (EBITDA margin 1.4%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Kapsin Pharma is -5% over three years and 9% over five years. In the latest year (FY 2025) revenue rose 8%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Kapsin Pharma is 08AAGCK1876P1ZT, registered in Rajasthan.

The CIN (Corporate Identification Number) of Kapsin Pharma is U24299GJ2016PTC092322. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Kapsin Pharma has 1 court case on record: 1 filed against it.

Kapsin Pharma was incorporated on 03 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Kapsin Pharma by revenue are Pazia Pharmaceuticals Private Limited, Apn Biotech Private Limited, Vmedicare Private Limited, Pyramid Formulations Private Limited, Inspride Lab Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Prince Kapoor ceased to be Director on 14 Aug 2019. Gajraj Sharma was appointed as Director on 03 Jun 2016. Mukesh Sharma was appointed as Director on 03 Jun 2016.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available